UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 12, 2006
CARDIOGENESIS CORPORATION
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
California
(State or other jurisdiction
of incorporation)
|
|
000-28288
(Commission File Number)
|
|
77-0223740
(IRS Employer
Identification No.) |
26632 Towne Centre Drive, Suite 320
Foothill Ranch, CA 92610
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (714) 649-5000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 8.01. Other Events
On April 12, 2006, the Company issued a press release regarding the delay in filing the Company’s
Form 10-K for the year ended December 31, 2005
The press release is attached hereto as Exhibit 99.01 and is incorporated herein by this reference.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
| |
|
|
| Exhibit Number |
|
Exhibit Title or Description |
99.01
|
|
Press release of Cardiogenesis Corporation dated April 12,
2006 (furnished pursuant to Item 2.02) |